ibrutinib
janssen,abbvie
['mantle,(-dismantle)', 'ibru', 'lymphoma']
the largest trial to date in mantle cell lymphoma shows that adding the btk inhibitor #ibrutinib to soc treatment improves pfs by 50%. #asco22 #asco2022
Latest medical news, articles, and features from Medscape Pharmacists.